awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33367787-10089A84-4901-4397-9E0E-78FF3DA4FE4C
Q33367787-10089A84-4901-4397-9E0E-78FF3DA4FE4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33367787-10089A84-4901-4397-9E0E-78FF3DA4FE4C
A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.
P478
Q33367787-10089A84-4901-4397-9E0E-78FF3DA4FE4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33367787-10089A84-4901-4397-9E0E-78FF3DA4FE4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c34e7617dfbb7412f325b2e9e33807cbfe1af26
P478
9
http://www.w3.org/2001/XMLSchema#string